Epygen Biotech
PrivateLast Round
Grant
Apr 11, 2022
Total Funding Raised
$3.16M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
Epygen Biotech is a biotechnology company that specializes in the research and manufacturing of therapeutic proteins for oncology, cardiovascular, and immune disorders, as well as vaccines.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clean Manufacturing
Business Model
B2B
Customer Profile
Services & Consulting, Data as a Service
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Epygen Biotech Comparables
Compare Epygen Biotech with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Dyadic International Inc | 72% | |
| Creative Enzymes | 72% | |
| Enzymaster | 68% |
Epygen Biotech Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Apr 11, 2022 | ||||
| Early Funding | May 10, 2018 |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 29, 2026
Monthly visitors increased 1856% MoM, reaching 6.7K.
- Jan 20, 2026
Monthly visitors increased 713% MoM.
Epygen Biotech Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Epygen Biotech's valuation, stock price, and market status.
Is Epygen Biotech a public or private company?
Epygen Biotech is a private company.
What is the current stock price of Epygen Biotech?
Epygen Biotech is a private company with no public stock price. Caplight tracks Epygen Biotech's secondary market activity and provides MarketPrice™ estimates to Caplight users.
How much is Epygen Biotech worth (valuation)?
Valuation information for Epygen Biotech is not publicly available.
Can I buy Epygen Biotech stock?
Epygen Biotech shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Epygen Biotech's last funding round?
Epygen Biotech's most recent funding round was Grant on April 11, 2022.
Who are the main investors in Epygen Biotech?
Investor information for Epygen Biotech is not publicly disclosed.
Will Epygen Biotech IPO soon?
No public IPO plans have been announced for Epygen Biotech.
How can I track Epygen Biotech secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Epygen Biotech's secondary market activity and sign up for updates.